Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Depreciation & Amortization (CF): 2019-2025

Historic Depreciation & Amortization (CF) for Benitec Biopharma (BNTC) over the last 5 years, with Jun 2025 value amounting to $14,000.

  • Benitec Biopharma's Depreciation & Amortization (CF) fell 46.15% to $14,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $66,000, marking a year-over-year decrease of 24.14%. This contributed to the annual value of $66,000 for FY2025, which is 24.14% down from last year.
  • According to the latest figures from Q2 2025, Benitec Biopharma's Depreciation & Amortization (CF) is $14,000, which was up 7.69% from $13,000 recorded in Q1 2025.
  • Benitec Biopharma's Depreciation & Amortization (CF)'s 5-year high stood at $67,000 during Q1 2021, with a 5-year trough of $6,000 in Q2 2022.
  • Over the past 3 years, Benitec Biopharma's median Depreciation & Amortization (CF) value was $20,000 (recorded in 2023), while the average stood at $20,600.
  • In the last 5 years, Benitec Biopharma's Depreciation & Amortization (CF) slumped by 88.46% in 2022 and then skyrocketed by 250.00% in 2023.
  • Over the past 5 years, Benitec Biopharma's Depreciation & Amortization (CF) (Quarterly) stood at $55,000 in 2021, then declined by 25.45% to $41,000 in 2022, then tumbled by 58.54% to $17,000 in 2023, then dropped by 17.65% to $14,000 in 2024, then crashed by 46.15% to $14,000 in 2025.
  • Its Depreciation & Amortization (CF) stands at $14,000 for Q2 2025, versus $13,000 for Q1 2025 and $14,000 for Q4 2024.